期刊文献+

血清FGF21与腹内脂肪及胰岛素抵抗相关性研究

下载PDF
导出
摘要 目的探讨2型糖尿病(T2DM)患者血浆中人碱性成纤维细胞生长因子21(FGF21)水平与腹内脂肪及胰岛素抵抗的相关性。方法T2DM患者124例,按照腹内脂肪四分位法分为四组,分析腹内脂肪与FGF21和胰岛素抵抗的相关性。结果腹内脂肪越多的组别其FGF21水平也越高,且胰岛素抵抗指数越大,FGF21水平与腹内脂肪成正相关,差异有统计学意义;胰岛素抵抗不是导致FGF21升高的独立危险因素。结论T2DM患者腹内脂肪与FGF2l正相关,FGF21可能是T2DM合并肥胖发病的重要的危险因素之一。 Objective To study the relationship among plasma FGF21 level, intra-abdominal fat and insulin resistance in patients with type 2 diabetes mellitus. Methods In our hospital in patients with type 2 diabetes mellitus in intra-abdominal fat four quartiles were divided into four groups, compare the FGF21 levels and insulin resistance in the relationship, and to study the correlation between visceral fat and FGF21 and insulin resistance. Results Visceral fat more groups FGF21 levels and insulin resistance index is larger, the level of FGF21 is positively correlated with visceral fat, RZ=0.9889, the difference was statistically significant; insulin resistance is not independent risk factor of FGF21. Conclusion There is a significant positive correlation in patients with type 2 diabetes mellitus in visceral adipose tissue and FGF21, FGF21 may be one of the important risk factors of type 2 diabetes with obesity.
机构地区 杭州解放军第
出处 《浙江临床医学》 2016年第1期41-42,共2页 Zhejiang Clinical Medical Journal
基金 南京军区医学科技创新课题面上项目
关键词 2型糖尿病 成纤维细胞生长因子 胰岛素抵抗 Type 2 diabetes mellitus Fibroblast growth factor Insulin resistance
  • 相关文献

参考文献14

  • 1Hotamisligil GS.Molecular mechanisms of insulin resistance and the role of the adipocyte.lnt J Obes P, elat Metab Disord,2{100,24(Suppl 4):S23-27.
  • 2Amer P.Free fatty acids-do they play a central role in type 2 diabetes?Diabetes Obes Metab,2001,3(Suppl 1):S11-19.
  • 3Hishinuma A,Majima M,Kurabayashi H,et al.lnsulin resistance m patients with stroke is related to visceral fat obesity and adipocytokines.J Stroke Cerebrovasc Dis,2()08,17(4):175-180.
  • 4Giorgos K.Sakkas,Christina K,et al.Liver farvisceral adiposity,and sleep disturbances contribute to the devdopment of insulin resistance and glucose intolerance in nondiabetic dialysis patients.AJP-P, egu Physiol,2008, 295(6):1721-1729.
  • 5徐琳,周博,孙宏志.成纤维细胞生长因子21的研究进展[J].医学综述,2010,16(19):2918-2921. 被引量:5
  • 6王淑琴,王建勇,陈永谦,满洁.2型糖尿病并脂肪肝患者血浆FGF21水平测定及临床意义探讨[J].齐齐哈尔医学院学报,2013,34(14):2036-2037. 被引量:7
  • 7朱蓓,王进红,成兴波,蒋伏松.2型糖尿病患者血清成纤维细胞生长因子21水平的变化及其临床意义[J].苏州大学学报(医学版),2009,29(3):504-507. 被引量:10
  • 8董靖,杨刚毅,李伶,刘东方,李钶,李生兵,陈文雯.重组促胰岛素分泌素对2型糖尿病患者血浆FGF-21水平的影响[J].中国老年学杂志,2011,31(9):1499-1501. 被引量:2
  • 9Guidorizzi de Siqueira A C,Cotrim H P,Rocha R,et al.Non-alcoholic t;atty liver disease and insulin resistance: importance of risk factors and histological spectrum .EurJ Gastroenterol Hepatol,201 1,17(8):837-841.
  • 10Kurosu H, Choi M, Ogawa Y, et al. Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isofomas determines metabolic activity of FGF19 and FGF21. J Biol Chem, 2012,282(37) :26687-26695.

二级参考文献106

  • 1王会岩,张耀方,万晓珊,解佳森,肖业臣,李校堃.人成纤维细胞生长因子-21分泌型表达及鉴定[J].吉林农业大学学报,2009,31(3):255-257. 被引量:9
  • 2陆泽元,林怿昊,邵豪,邹钢.血脂紊乱类型与胰岛素抵抗的关系[J].中华内分泌代谢杂志,2004,20(5):447-449. 被引量:33
  • 3高玲,陈琴,康丽娜,王涟,宋杰,徐标.糖尿病和非糖尿病动脉粥样硬化兔模型的建立[J].中国实验动物学报,2007,15(3):179-182. 被引量:18
  • 4刘建雷,李伶,杨刚毅.成纤维细胞生长因子-21的研究进展[J].检验医学与临床,2007,4(7):642-643. 被引量:5
  • 5Itoh N, Omitz DM. Evolution of the FGF and FGFR gene families[J]. Trends Genet, 2004,20(11): 563-569.
  • 6Kharitonenkov A, Shiyanova TL, Koester A, et al. FGF-21 as a novel metabolic regulator[J]. J Clin Invest, 2005, 115 (6): 1627-1635.
  • 7Nishimura T, Nakatake Y, Konishi M, et al. Identification of a novel FGF, FGF-21, preferentially expressed in the liver[J]. Biochim Biophys Acta, 2000, 1492(1): 203-206.
  • 8Zhang X, Yeung DC, Karpisek M, et al. Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans[J]. Diabetes, 2008, 57(5): 1246-1253.
  • 9Kharitonenkov A, Wroblewski VJ, Koester A, et al. The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21[J]. Endocrinology, 2007, 148(2): 774- 781.
  • 10Wente W, Efanov AM, Brenner M, et al. Fibroblast growth factor-21 improves pancreatic B-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways[J]. Diabetes, 2006, 55(9): 2470- 2478.

共引文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部